Citations

Showing 10 of 108073 citations.

P1125: DURABLES RESPONSES ACHIEVED WITH ANTI-CD19 ALLOGENEIC CAR T ALLO-501/501A IN PHASE 1 TRIALS OF AUTOLOGOUS CAR T-NAÏVE PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL)
Lekakis, Lazaros J. , Eradat, Herbert, Tees, Michael, Vos, Sven de , Nath, Rajneesh , Stevens, Don A., Malik, Shahbaz A. , Popplewell, Leslie , Goyal, Lovely, Navale, Lynn, Kaufman, Gregory, Kai, Kazuharu, Balakumaran, Arun, Neelapu, Sattva S. , Muñoz, Javier , Locke, Frederick L. , Hamadani, Mehdi , Oluwole, Olalekan O. , Perales, Miguel‐Angel , Miklos, David B. , Fisher, Paul Graham

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e8808264

10.1097/01.hs9.0000971396.88082.64 Get It

P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY
Cohen, Jonathon B. , Eyre, Toby A. , Woyach, Jennifer A. , Seymour, John F. , Wang, Michael , Loubert, Angély , Hess, Lisa M. , Abada, Paolo, Mato, Anthony R. , Roeker, Lindsey E. , Cheah, Chan Y. , Patel, Krish , Wang, Yucai , Payakachat, Nalin , Ghia, Paolo

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e34270c5

10.1097/01.hs9.0000971344.34270.c5 Get It

P871: IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS WITH AN INADEQUATE RESPONSE TO FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT): RESULTS FROM KARMMA-2 COHORT 2C
Alsina, Melissa , Dhodapkar, Madhav V. , Patel, Krina K. , Vij, Ravi , Leleu, Xavier , Egan, Daniel , Ran, Reshef, Truppel-Hartmann, Anna, Basudhar, Debashree, Thompson, Ethan, Zheng, Xirong, Zhong, Xiaobo , Greggio, Chiara, McKiver, Mihaela Popa, Alfonso, Marlene Carrasco, Berdeja, Jesús G. , Richard, Shambavi , Bergsagel, P. Leif , Usmani, Saad Z. , Zheng, Xirong, Siegel, David S.

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e90596a3

10.1097/01.hs9.0000970388.90596.a3 Get It

P951: IMPACT OF MEASURABLE RESIDUAL DISEASE (MRD) DIFFERENCES ON PROGRESSION-FREE SURVIVAL (PFS): AN AGGREGATE DATA ANALYSIS FROM RANDOMIZED CLINICAL TRIALS IN MULTIPLE MYELOMA (MM)
Núñez, Jorge, Munshi, Nikhil C. , Durie, Brian G.M. , Paiva, Bruno , Zherniakova, Anastasiia , Rodríguez‐Otero, Paula , Shi, Qian , Miguel, Jesús F. San

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e04566c4

10.1097/01.hs9.0000970708.04566.c4 Get It

P975: THREE-DIMENSIONAL TELOMERE PROFILING PREDICTS RISK OF RELAPSE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
Kumar, Shaji , Kyle, Robert A. , Louis, Sherif, Rajkumar, S. Vincent , Jevremović, Dragan , Mai, Sabine

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e07945f9

10.1097/01.hs9.0000970804.07945.f9 Get It

P354: MULTI-INSTITUTIONAL STUDY EVALUATING THE IMPACT ON SURVIVAL OF NEWER TREATMENT COMBINATIONS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
Narra, Ravi , Desai, Shreya, Correia, Guilherme Sacchi de Camargo, Palmisiano, Neil , Curran, Emily , Shallis, Rory M. , Litzow, Mark R. , Badar, Talha , Atallah, Ehab , Mims, Alice S , Kota, Vamsi , Patel, Anand , DuVall, Adam , Omer, Zulfa , Advani, Anjali S.

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e9392932

10.1097/01.hs9.0000968328.93929.32 Get It

S202: CARTITUDE-1 FINAL RESULTS: PHASE 1B/2 STUDY OF CILTACABTAGENE AUTOLEUCEL IN HEAVILY PRETREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Munshi, Nikhil C. , Martin, Tom, Deol, Abhinav , Htut, Myo , O’Donnell, Elizabeth , Jackson, Carolyn C. , Yeh, Tzu‐Min, Banerjee, Arnob , Zudaire, Enrique, delCorral, Christopher, Pacaud, Lida , Usmani, Saad Z. , Berdeja, Jesús G. , Jakubowiak, Andrzej , Agha, Mounzer , Cohen, Adam D. , Lesokhin, Alexander M. , Lin, Yi , Madduri, Deepu , Jagannath, Sundar

Mayo Clinic

HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e6102468

10.1097/01.hs9.0000967720.61024.68 Get It

Relationships among intragastric meal distribution during gastric emptying scintigraphy, water consumption during water load satiety testing, and symptoms of gastroparesis
Parkman, Henry P. , Wilson, Laura , Silver, Paul G., Maurer, Alan H. , Sarosiek, Irene , Bulat, Robert, Kuo, Braden , Grover, Madhusudan , Farrugia, Gianrico , Shulman, Robert J. , Malik, Zubair , Miriel, Laura , Tonascia, James , Hamilton, Frank A., Pasricha, Pankaj J. , McCallum, Richard W. , Koch, Kenneth L. , Malik, Zubair , Parkman, H P , Kuo, Braden , Silver, Paul, Chumpitazi, Bruno P. , Abell, Thomas L.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | August 8, 2023 | Volume: 325 | Issue: 5 | Pages: G407-G417

10.1152/ajpgi.00065.2023 | PMID 37552206 Get It

IMD0 and WLST were assessed for their clinical utility in assessing patients with symptoms of gastroparesis. Low IMD0 is associated with less gastric retention and less heartburn. Volume of water consumed during WLST, while associated with IMD0, has associations with early satiety, postprandial fullness, loss of appetite, and nausea. IMD0 and WLST appear to overlap somewhat in their assessment of gastric physiology in adults with symptoms of gastroparesis but relate to different dyspeptic symptoms.